Sumitomo Chemical Company, Limited
【Sumitomo Chemical】Reversal of Equity Method Investment Loss｜May 2026
Sumitomo Chemical recorded a reversal of equity method investment loss in the fourth quarter of fiscal year 2026. There was no impact on consolidated results, and the content reflects the figures in the individual financial statements.
Key Figures
- Reversal amount of equity method investment loss: △13,361 million yen
- Valuation loss recognized in the third quarter of fiscal year 2026: 13,361 million yen
- Total valuation loss amount: Unknown
AI要約
Financial Performance Overview
Sumitomo Chemical announced that it reversed a valuation loss on equity method investments in the fourth quarter of fiscal year 2026. The target was Type A common shares of Rabigh Refining & Petrochemical Company, an equity-method affiliate, with a total valuation loss of △13,361 million yen. This was due to a recovery in the fair value of the shares and does not affect the consolidated financial results.
Impact on Shareholders and Future Outlook
The reversal of valuation loss is only reflected in the individual financial statements and has no effect on the consolidated results, thus the direct impact on shareholders and investors is limited. The company also states it will continue to monitor fluctuations in the valuation of affiliated companies’ shares and manage assets appropriately.
Sumitomo Chemical Co., Ltd.
Company overview · Stock price · Financial data · All IR
